Bausch Health Cos
Bausch Health Companies Inc., commonly referred to as Bausch Health, is a prominent global healthcare company headquartered in Canada. Founded in 2013, the company has rapidly established itself in the pharmaceutical and medical device industries, focusing on eye health, gastrointestinal health, and dermatology. With a diverse portfolio of innovative products, Bausch Health is renowned for its commitment to improving patient outcomes through advanced therapies and technologies. Key offerings include prescription medications, over-the-counter products, and surgical devices, all designed to address critical health needs. Bausch Health has achieved significant milestones, including strategic acquisitions that have bolstered its market position. The company continues to be a leader in the healthcare sector, dedicated to enhancing the quality of life for patients worldwide.
DitchCarbon Score
How does Bausch Health Cos's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bausch Health Cos's score of 39 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Bausch Health Cos's reported carbon emissions
In 2023, Bausch Health Cos reported total greenhouse gas emissions of approximately 65,518,000 kg CO2e from Scope 2, 49,906,000 kg CO2e from Scope 1, and 38,011,000 kg CO2e from Scope 3 emissions. This reflects a commitment to transparency in their climate impact, with emissions data disclosed across all three scopes. Bausch Health has set ambitious targets to reduce its greenhouse gas emissions. The company aims to achieve a 42% reduction in both Scope 1 and Scope 2 emissions by 2030, using 2020 as the baseline year. Additionally, they are committed to measuring and reducing their Scope 3 emissions, which include indirect emissions from their value chain. The company's emissions have shown fluctuations over the years, with Scope 1 emissions recorded at 54,718,000 kg CO2e in 2016, decreasing to 46,686,000 kg CO2e in 2022. This indicates a positive trend towards reducing direct emissions from their operations. Bausch Health's climate commitments align with industry standards, reflecting their dedication to addressing climate change and contributing to global sustainability efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2018 | 2019 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 547,180,000 | 000,000,000 | - | 00,000,000 | 00,000,000 |
| Scope 2 | - | - | - | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | 000,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bausch Health Cos is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
